MedHubMedical calculators

CKD-EPI 2021: eGFR

Estimates eGFR with the 2021 CKD-EPI creatinine equation, without a race coefficient, and reports the KDIGO G stage.

When to use

Adults with stable creatinine, to estimate kidney function, stage CKD and adjust drug doses.

Pearls and pitfalls
  • Not valid in acute kidney injury: creatinine has not caught up with the drop in filtration.
  • Very high or very low muscle mass (amputees, sarcopenia, bodybuilders) distorts the result. Consider cystatin C.
  • Result is indexed to 1.73 m². For drug dosing at weight extremes, de-index by body surface area.
  • Replaces CKD-EPI 2009, which used a race factor. Recommended by NKF and ASN since 2021.

Sex

years

Fill in the fields to see the result.

Interpretation

1 to 14 points: G5: kidney failure
Assess dialysis or transplant with nephrology.
15 to 29 points: G4: severely decreased
Refer to nephrology. Plan kidney replacement therapy. Avoid nephrotoxins and contrast.
30 to 44 points: G3b: moderately to severely decreased
Adjust doses. Screen for anemia, mineral bone disorder and acidosis. Consider nephrology.
45 to 59 points: G3a: mildly to moderately decreased
Adjust renally cleared drugs. Repeat in 3 months to confirm chronicity.
60 to 89 points: G2: mildly decreased
Check albuminuria. Control blood pressure and glucose.
90 to 247 points: G1: normal or high
CKD only if another marker of kidney damage is present (albuminuria, structural change).

Formula

eGFR = 142 × min(Scr/κ, 1)^α × max(Scr/κ, 1)^-1.200 × 0.9938^age × 1.012 [if female]
κ = 0.7 (female) or 0.9 (male); α = -0.241 (female) or -0.302 (male); Scr in mg/dL.

Evidence

Developed in 8,254 participants and validated in 4,050 from 12 cohorts. Smaller bias between Black and non-Black participants than the 2009 equation without race.

References

  1. Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953
  2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. doi:10.1016/j.kint.2023.10.018

Frequently asked questions

What is CKD-EPI 2021?

Estimates eGFR with the 2021 CKD-EPI creatinine equation, without a race coefficient, and reports the KDIGO G stage. Adults with stable creatinine, to estimate kidney function, stage CKD and adjust drug doses.

When should I use CKD-EPI 2021?

Adults with stable creatinine, to estimate kidney function, stage CKD and adjust drug doses.

How is CKD-EPI 2021 calculated?

eGFR = 142 × min(Scr/κ, 1)^α × max(Scr/κ, 1)^-1.200 × 0.9938^age × 1.012 [if female] κ = 0.7 (female) or 0.9 (male); α = -0.241 (female) or -0.302 (male); Scr in mg/dL.

How should the result be interpreted?

1 to 14 points: G5: kidney failure. Assess dialysis or transplant with nephrology. 15 to 29 points: G4: severely decreased. Refer to nephrology. Plan kidney replacement therapy. Avoid nephrotoxins and contrast. 30 to 44 points: G3b: moderately to severely decreased. Adjust doses. Screen for anemia, mineral bone disorder and acidosis. Consider nephrology. 45 to 59 points: G3a: mildly to moderately decreased. Adjust renally cleared drugs. Repeat in 3 months to confirm chronicity. 60 to 89 points: G2: mildly decreased. Check albuminuria. Control blood pressure and glucose. 90 to 247 points: G1: normal or high. CKD only if another marker of kidney damage is present (albuminuria, structural change).

What are the limitations and pitfalls?

Not valid in acute kidney injury: creatinine has not caught up with the drop in filtration. Very high or very low muscle mass (amputees, sarcopenia, bodybuilders) distorts the result. Consider cystatin C. Result is indexed to 1.73 m². For drug dosing at weight extremes, de-index by body surface area. Replaces CKD-EPI 2009, which used a race factor. Recommended by NKF and ASN since 2021.

What is the evidence behind it?

Developed in 8,254 participants and validated in 4,050 from 12 cohorts. Smaller bias between Black and non-Black participants than the 2009 equation without race. Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737-1749.

Which calculators are related?

CURB-65: pneumonia severity: CURB-65: confusion, urea, respiratory rate, blood pressure and age 65 or over. 0 to 1 low risk, 2 intermediate, 3 or more high risk.

What are the sources?

Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737-1749. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314.

Updated